-

Global Investors to Bring as Much As US$52B In Capital to Fund Canadian Healthcare Innovations

Attending the Ontario Bioscience Innovation Organization Investment Summit and Early Technology Showcase February 9-11

TORONTO--(BUSINESS WIRE)--This week, the Ontario Bioscience Innovation Organization (OBIO), a membership-based not-for-profit organization, is set to bring investors from around the world to its annual OBIO Investment Summit (OIS) and Early Technology Showcase (ETS), which showcases Canada’s leading innovations in health sciences, including biotech and medtech. According to OBIO’s analysis, the registered investors have approximately US$52 billion combined in unallocated and available funds to invest during the summit.

As part of its annual OBIO Investment Summit which takes place virtually starting February 9 to Friday, February 11, 2022, over 50 emerging Canadian companies will be in attendance, looking to bring their breakthrough innovations to market as part of Canada’s thriving health sciences technology industry.

“OBIO is welcoming over 100 global investors to their 2022 annual Investment Summit who will have the unique opportunity to access the best Canadian innovations in this sector,” says Dr. Maura Campbell, CEO of OBIO. “The summit has built on its strengths each year since 2018, and to date 101 companies have gone on to successfully raise over $1 billion in investment to boost Canada’s economy and its health sciences industry.”

The summit showcases investable companies, including the Early Technology Showcase, which this year, highlights 10 of Canada’s leading health research institutions presenting their latest breakthrough technologies, from mental health and cancer detection to AI and stem cell therapies. Together, the OIS and ETS bring together global investors, high potential Canadian companies, and top Canadian research institutions with the goal of bringing venture capital investment to Canada.

“The OBIO Investment Summit is a great venue for a preselected group of Canadian life sciences companies to showcase their technologies and connect to a diverse group of global investors and potential partners,” says Jacki Jenuth, Partner at Lumira Ventures. “We look forward each year to connecting with entrepreneurs at the Summit, learning of the opportunity for their business and being able to share some of our experience and insight from 20+ years of building great life sciences companies.”

For more information on the lineup of companies presenting at the 2022 OBIO Investment Summit or to register for attendance, visit www.obioinvestmentsummit.com.

About OBIO

The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies positioning Canada as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.

For more information, please visit www.obio.ca and follow OBIO on Twitter @OBIOscience.

Contacts

Media:
Elizabeth Glassen, BlueSky Communications
eglassen@blueskycommunications.com, 647-309-0141

Industry:

Ontario Bioscience Innovation Organization

Release Versions
English

Contacts

Media:
Elizabeth Glassen, BlueSky Communications
eglassen@blueskycommunications.com, 647-309-0141

More News From Ontario Bioscience Innovation Organization

St. Joseph’s Healthcare Hamilton Adopts Made-in-Canada Technology for Real-Time Equipment Tracking and Improved Patient Experience

WATERLOO, Ontario & HAMILTON, Ontario--(BUSINESS WIRE)--Studies across the world have shown that, on average, hospitals tend to use less than half of their medical assets at any given time. In addition, hospitals are likely to hold on average three times as much inventory as they need. In a facility the size of St. Joseph’s Healthcare Hamilton Charlton Campus (St. Joe’s), which has 600 beds, specialized equipment such as mattresses designed to reduce pressure sores and IV poles travel with pati...

Canadian-Made Technology Gives Hospital Teams Clearer Images at the Bedside

TORONTO--(BUSINESS WIRE)--Each year, more than 20 million diagnostic X-ray procedures are performed in Canada according to Health Canada. While regular X-rays are used every day in hospitals, they sometimes miss important details – depending on the case and imaging conditions. That’s because bones and other body parts can overlap in the images. In collaboration with OBIO®, University Health Network (UHN), Canada’s leading hospital and the No. 1 publicly funded hospital in the world, is adding a...

OBIO® Drives AI Innovation in Critical Care with The Ottawa Hospital’s Use of the Extubation Advisor

TORONTO--(BUSINESS WIRE)--OBIO®, through its Life Sciences Critical Technology and Commercialization (LSCTC) Centre for Excellence, is supporting the adoption of the Extubation Advisor (EA) at The Ottawa Hospital (TOH). Developed by Canadian company Therapeutic Monitoring Systems Inc. (TMS), this AI-powered clinical support tool is designed to assist clinicians in making extubation decisions in intensive care units. The EA was adopted after successful evaluations were completed at TOH and Unity...
Back to Newsroom